Potential drug-drug interactions when managing status epilepticus patients in intensive care: A cohort study.

Abstract

AIMS:

The risk for drug-drug interactions (DDIs) associated with antiseizure drugs (ASDs) used to manage status epilepticus (SE) patients in the intensive care unit (ICU) has been poorly investigated. We aimed to quantify and describe those potential DDIs and determine SE patient risk profiles.

METHODS:

We conducted an observational bi-centric cohort study including all SE patients admitted to the ICU in the period 2016-2020.

RESULTS:

Overall, 431 SE patients were included and 5504 potential DDIs were identified including 1772 DDIs (33%) between ASDs, 2610 DDIs (47%) between ASDs and previous usual treatments (PUTs), and 1067 DDIs (20%) between ASDs and ICU treatments (ICUTs). DDIs were moderate (n = 4871), major (n = 562) or severe (n = 16). All patients exhibited potential DDIs, which were major-to-severe DDIs in 47% of the cases. DDIs were pharmacokinetic (n = 1972, 36%), mostly involving cytochrome P450 modulators, and pharmacodynamic (n = 3477, 64%), mainly leading to increased sedation. ASD/PUT DDIs were the most frequent and severe. Age, PUT and ASD drug numbers and length of ICU stay were significantly associated with increased DDI number. We identified four SE patient profiles with different DDI risks and outcomes including (1) epileptic or brain trauma patients, (2) withdrawal syndrome patients, (3) older patients with comorbidities and (4) self-poisoned patients with psychiatric disorders and/or past epilepsy.

CONCLUSION:

SE patients are subject to potential DDIs between ASDs, ASD/PUT and ASD/ICUT. Major-to-severe DDIs mostly occur between ASDs and PUTs. Physicians should pay attention to SE patient characteristics and history to limit DDI numbers and prevent their consequences.

• Authors: Clémentine Le Roux, Alexandre Destère, Sarah Hervy, Célia Lloret-Linares, Jean Reignier, Pascal Caillet, Pascale Jolliet, Bruno Mégarbane, David Boels
• Journal: British journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 88 Issue 5 Pg. 2408-2418 (05 2022) ISSN: 1365-2125 [Electronic] England
• PMID: 34907586 (Publication Type: Journal Article, Observational Study)
• Copyright: © 2021 British Pharmacological Society.

Topics

• Cohort Studies
• Critical Care
• Drug Interactions
• Humans
• Intensive Care Units
• Status Epilepticus (drug therapy)